Bengaluru, India

Gurulingappa Hallur

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: The Innovations of Gurulingappa Hallur: A Pioneer in Cancer Treatment

Introduction

Gurulingappa Hallur, an accomplished inventor based in Bengaluru, India, has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio of seven patents, he is recognized for his innovative approaches to developing novel compounds aimed at treating various diseases, particularly cancer.

Latest Patents

Among his notable inventions, Hallur's latest patents include "Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer." This groundbreaking application presents novel heterocyclic compounds and their pharmaceutically acceptable salts, designed to inhibit the ERK1/2 pathways that are often dysregulated in cancer. By administering these compounds in therapeutically effective amounts, Hallur's work opens new avenues for treating conditions associated with abnormal cellular proliferation, specifically cancer. Another significant patent pertains to "Heterocyclic compounds as PAD inhibitors," which details various heterocyclic compounds and their derivatives. These compounds show promise for treating serious disorders, including rheumatoid arthritis, cancer, and multiple sclerosis, thus highlighting their therapeutic potential.

Career Highlights

Gurulingappa Hallur has worked with esteemed companies, including Asana Biosciences and Jubilant Epipad. His dedication to research and innovation in medicinal chemistry has positioned him as a key figure in the development of new therapies that could revolutionize treatment options for patients suffering from debilitating diseases.

Collaborations

Throughout his career, Hallur has collaborated with notable professionals in his field, including Aranapakam Mudumbai Venkatesan and Scott Kevin Thompson. These partnerships have fostered a rich environment for innovation, facilitating the exchange of ideas and knowledge critical to advancing medical research.

Conclusion

Gurulingappa Hallur exemplifies the spirit of innovation with his extensive contributions to the field of cancer treatment and beyond. His patents not only reflect his commitment to scientific advancement but also underscore the potential impact of his work on global health. As he continues to develop new therapeutic strategies, the medical community eagerly anticipates the outcomes of his groundbreaking research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…